Transimmune - Crunchbase Company Profile & Funding

Q: Who invested in Transimmune?

Transimmune is funded by Bill & Melinda Gates Foundation.

Q: When was the last funding round for Transimmune?

Transimmune closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Transimmune raised to date?

Transimmune has raised obfuscated.

Overview

Transimmune

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Transimmune

CB Rank

131248

Transimmune is a pioneering dendritic cell therapy business that has discovered how dendritic cells are produced biologically.

Founded

obfuscation

Private

Seed

Düsseldorf, Nordrhein-Westfalen, Germany

1-10

transimmune.com

Biotechnology

Product Research

Funding Rounds

Seed

OBF

obfuscation

Details

Legal Name

Transimmune AG

Operating Status

Active

Company Type

For Profit

About the Company

Transimmune is a provider of dendritic cell therapy, having discovered the physiological process by which dendritic cells are produced.

Phone Number

+49 21164136110

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

DC-Stim

A dendritic cell therapy designed to stimulate immune responses against cancer and infectious diseases.

DC-Tol

A dendritic cell therapy aimed at inducing immune tolerance for autoimmune diseases.

Research & Development

Transimmune is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed
obfuscated obfuscation	Seed Round - Transimmune	1	obfuscated obfuscation	Bill & Melinda Gates Foundation	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Bill & Melinda Gates Foundation	Yes	Seed Round - Transimmune	—
Bill & Melinda Gates Foundation	Yes	Seed Round - Transimmune	—
Bill & Melinda Gates Foundation	Yes	Seed Round - Transimmune	—
Bill & Melinda Gates Foundation	Yes	Seed Round - Transimmune	—
Bill & Melinda Gates Foundation	Yes	Seed Round - Transimmune	—